Abstract
Autism Spectrum Disorder is a developmental condition associated with impairments in communication and social interactions, and repetitive and restricted behavior or interests. Autistic individuals are more likely to experience gastrointestinal (GI) symptoms than neurotypical individuals. This may be partially due to dysbiosis of the gut microbiome. In this article, we describe the interaction of the microbiome and immune system on autism etiology. We also summarize the links between the microbiome and gastrointestinal and related symptoms among autistic individuals. We report that microbial interventions, including diet, probiotics, antibiotics, and fecal transplants, and immune-modulating therapies such as cytokine blockade during the preconception, pregnancy, and postnatal period may impact the neurodevelopment, behavior, and gastrointestinal health of autistic individuals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abazyan B, Nomura J, Kannan G et al (2010) Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68(12):1172–1181
Abrahams BS, Geschwind DH (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9(5):341–355
American Psychiatric Association D, Association AP (2013) Diagnostic and statistical manual of mental disorders: DSM-5, vol 5. American Psychiatric Association, Washington
Ardalan M, Chumak T, Vexler Z, Mallard C (2019) Sex-dependent effects of perinatal inflammation on the brain: implication for neuro-psychiatric disorders. Int J Mol Sci 20(9):2270
Arnold LE, Luna RA, Williams K et al (2019) Probiotics for gastrointestinal symptoms and quality of life in autism: a placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 29(9):659–669
Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J (2011) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25(1):40–45
Bacchelli E, Maestrini E (2006) Autism spectrum disorders: molecular genetic advances. Wiley Online Library, pp 13–23
Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R (2011) Why are autism spectrum conditions more prevalent in males? PLoS Biol 9(6):e1001081
Blessing EM, Murty VP, Zeng B, Wang J, Davachi L, Goff DC (2020) Anterior hippocampal–cortical functional connectivity distinguishes antipsychotic naïve first-episode psychosis patients from controls and may predict response to second-generation antipsychotic treatment. Schizophr Bull 46(3):680–689
Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D (2017) Endocannabinod signal dysregulation in autism spectrum disorders: a correlation link between inflammatory state and neuro-immune alterations. Int J Mol Sci 18(7):1425
Careaga M, Murai T, Bauman MD (2017) Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates. Biol Psychiatry 81(5):391–401
Careaga M, Taylor SL, Chang C et al (2018) Variability in PolyIC induced immune response: implications for preclinical maternal immune activation models. J Neuroimmunol 323:87–93
Chakraborty P, Carpenter KL, Major S et al (2021) Gastrointestinal problems are associated with increased repetitive behaviors but not social communication difficulties in young children with autism spectrum disorders. Autism 25(2):405–415
Chaste P, Leboyer M (2022) Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci
Choi GB, Yim YS, Wong H et al (2016) The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351(6276):933–939
Comer AL, Carrier M, Tremblay M-È, Cruz-MartÃn A (2020) The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation. Front Cell Neurosci 274
Critchfield JW, Van Hemert S, Ash M, Mulder L, Ashwood P (2011) The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011
Croen LA, Zerbo O, Qian Y et al (2015) The health status of adults on the autism spectrum. Autism 19(7):814–823
Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M (2002) Activation of the inflammatory response system in autism. Neuropsychobiology 45(1):1–6
Daliri EB-M, Tango CN, Lee BH, Oh D-H (2018) Human microbiome restoration and safety. Int J Med Microbiol 308(5):487–497
Davies C, Mishra D, Eshraghi RS et al (2021) Altering the gut microbiome to potentially modulate behavioral manifestations in autism spectrum disorders: a systematic review. Neurosci Biobehav Rev 128:549–557
Doenyas C (2018) Gut microbiota, inflammation, and probiotics on neural development in autism spectrum disorder. Neuroscience 374:271–286
Emanuele E, Orsi P, Boso M et al (2010) Low-grade endotoxemia in patients with severe autism. Neurosci Lett 471(3):162–165
Estes ML, McAllister AK (2015) Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 16(8):469–486
Estes ML, McAllister AK (2016) Maternal immune activation: implications for neuropsychiatric disorders. Science 353(6301):772–777
Fatemi SH, Sidwell R, Akhter P et al (1998a) Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice. Synapse 29(1):84–88
Fatemi SH, Sidwell R, Kist D et al (1998b) Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero. Brain Res 800(1):1–9
Fatemi SH, Cuadra AE, El-Fakahany EE, Sidwell RW, Thuras P (2000) Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 11(7):1493–1496
Fatemi SH, Earle J, Kanodia R et al (2002) Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22(1):25–33
Foley KA, MacFabe DF, Vaz A, Ossenkopp K-P, Kavaliers M (2014) Sexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: implications for autism spectrum disorders. Int J Dev Neurosci 39:68–78
Fox-Edmiston E, Van de Water J (2015) Maternal anti-fetal brain IgG autoantibodies and autism spectrum disorder: current knowledge and its implications for potential therapeutics. CNS Drugs 29(9):715–724
Frye RE, Melnyk S, MacFabe DF (2013) Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl Psychiatry 3(1):e220–e220
Gebrayel P, Nicco C, Al Khodor S et al (2022) Microbiota medicine: towards clinical revolution. J Transl Med 20(1):1–20
Gilmore JH, Jarskog LF, Vadlamudi S (2005) Maternal poly I: C exposure during pregnancy regulates TNFα, BDNF, and NGF expression in neonatal brain and the maternal–fetal unit of the rat. J Neuroimmunol 159(1–2):106–112
Gładysz D, Krzywdzińska A, Hozyasz KK (2018) Immune abnormalities in autism spectrum disorder – could they hold promise for causative treatment? Mol Neurobiol 55(8):6387–6435
Grimaldi R, Gibson GR, Vulevic J et al (2018) A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome 6(1):1–13
Haida O, Al Sagheer T, Balbous A et al (2019) Sex-dependent behavioral deficits and neuropathology in a maternal immune activation model of autism. Transl Psychiatry 9(1):1–12
Harrington V, Lau L, Seddu K, Suez J (2021) Ecology and medicine converge at the microbiome-host interface. Msystems 6(4):e00756–e00721
Harvey L, Boksa P (2012) Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev Neurobiol 72(10):1335–1348
Heberling CA, Dhurjati PS, Sasser M (2013) Hypothesis for a systems connectivity model of autism spectrum disorder pathogenesis: links to gut bacteria, oxidative stress, and intestinal permeability. Med Hypotheses 80(3):264–270
Ho LKH, Tong VJW, Syn N et al (2020) Gut microbiota changes in children with autism spectrum disorder: a systematic review. Gut Pathogens 12(1):1–18
Holingue C, Newill C, Lee LC, Pasricha PJ, Daniele FM (2018) Gastrointestinal symptoms in autism spectrum disorder: a review of the literature on ascertainment and prevalence. Autism Res 11(1):24–36
Holingue C, Budavari AC, Rodriguez KM, Zisman CR, Windheim G, Fallin MD (2020a) Sex differences in the gut-brain axis: implications for mental health. Curr Psychiatry Rep 22(12):83. https://doi.org/10.1007/s11920-020-01202-y
Holingue C, Brucato M, Ladd-Acosta C et al (2020b) Interaction between maternal immune activation and antibiotic use during pregnancy and child risk of autism spectrum disorder. Autism Res 13(12):2230–2241
Holingue C, Poku O, Pfeiffer D, Murray S, Fallin MD (2021) Gastrointestinal concerns in children with autism spectrum disorder: a qualitative study of family experiences. Autism:13623613211062667
Hsiao EY, McBride SW, Hsien S et al (2013a) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155(7):1451–1463
Hsiao EY, McBride SW, Hsien S et al (2013b) The microbiota modulates gut physiology and behavioral abnormalities associated with autism. Cell 155(7):1451
Hullar MA, Fu BC (2014) Diet, the gut microbiome, and epigenetics. Cancer J 20(3):170
Inga Jácome MC, Morales Chacòn LM, Vera Cuesta H et al (2016) Peripheral inflammatory markers contributing to comorbidities in autism. Behav Sci 6(4):29
Inoue D, Kimura I, Wakabayashi M et al (2012) Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation. FEBS Lett 586(10):1547–1554
Inoue R, Sakaue Y, Kawada Y et al (2019) Dietary supplementation with partially hydrolyzed guar gum helps improve constipation and gut dysbiosis symptoms and behavioral irritability in children with autism spectrum disorder. J Clin Biochem Nutr 64(3):217–223
Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485–498
Kaidanovich-Beilin O, Lipina T, Vukobradovic I, Roder J, Woodgett JR (2011) Assessment of social interaction behaviors. J Vis Exp (48):e2473
Kang D-W, Adams JB, Gregory AC et al (2017) Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5(1):1–16
Kang D-W, Adams JB, Coleman DM et al (2019) Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. Sci Rep 9(1):1–9
Kentner AC, Bilbo SD, Brown AS et al (2019) Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model. Neuropsychopharmacology 44(2):245–258
Kim S, Kim H, Yim YS et al (2017) Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature 549(7673):528–532
Kim YS, Unno T, Kim B-Y, Park M-S (2020) Sex differences in gut microbiota. World J Men’s Health 38(1):48–60
Kim E, Paik D, Ramirez RN et al (2022) Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4+ T cells. Immunity 55(1):145–158.e7
Kong X, Liu J, Cetinbas M et al (2019) New and preliminary evidence on altered oral and gut microbiota in individuals with autism spectrum disorder (ASD): implications for ASD diagnosis and subtyping based on microbial biomarkers. Nutrients 11(9):2128
Kowash H, Potter H, Edye M et al (2019) Poly (I: C) source, molecular weight and endotoxin contamination affect dam and prenatal outcomes, implications for models of maternal immune activation. Brain Behav Immun 82:160–166
Lai M-C, Kassee C, Besney R et al (2019) Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry 6(10):819–829
Lammert CR, Frost EL, Bolte AC et al (2018) Cutting edge: critical roles for microbiota-mediated regulation of the immune system in a prenatal immune activation model of autism. J Immunol 201(3):845–850
Lipina TV, Zai C, Hlousek D, Roder JC, Wong AH (2013) Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J Neurosci 33(18):7654–7666
Liu F, Li J, Wu F, Zheng H, Peng Q, Zhou H (2019) Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review. Transl Psychiatry 9(1):1–13
Lyall K, Croen L, Daniels J et al (2017) The changing epidemiology of autism spectrum disorders. Annu Rev Public Health 38:81–102
MacFabe DF (2012) Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis 23(1):19260
MacFabe D (2013) Autism: metabolism, mitochondria, and the microbiome. Global Adv Health Med 2(6):52–66
Madra M, Ringel R, Margolis KG (2020) Gastrointestinal issues and autism spectrum disorder. Child Adolesc Psychiatr Clin N Am 29(3):501–513
Maenner MJ, Shaw KA, Bakian AV et al (2021) Prevalence and characteristics of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2018. MMWR Surveill Summ 70(11):1
Malkova NV, Collin ZY, Hsiao EY, Moore MJ, Patterson PH (2012) Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26(4):607–616
Marler S, Ferguson BJ, Lee EB et al (2017) Association of rigid-compulsive behavior with functional constipation in autism spectrum disorder. J Autism Dev Disord 47(6):1673–1681
Masi A, Quintana D, Glozier N, Lloyd A, Hickie I, Guastella A (2015) Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20(4):440–446
Mazina V, Gerdts J, Trinh S et al (2015) Epigenetics of autism-related impairment: copy number variation and maternal infection. J Dev Behav Pediatr 36(2):61–67
Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453(7195):620–625
Mead J, Ashwood P (2015) Evidence supporting an altered immune response in ASD. Immunol Lett 163(1):49–55
Meltzer A, Van de Water J (2017) The role of the immune system in autism spectrum disorder. Neuropsychopharmacology 42(1):284–298
Meyer U (2014) Prenatal poly (i: C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75(4):307–315
Meyer U (2019) Neurodevelopmental resilience and susceptibility to maternal immune activation. Trends Neurosci 42(11):793–806
Meyer U, Feldon J, Schedlowski M, Yee BK (2005) Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29(6):913–947
Meyer U, Feldon J, Dammann O (2011) Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69(8):26–33
Morais LH, Felice D, Golubeva AV, Moloney G, Dinan TG, Cryan JF (2018) Strain differences in the susceptibility to the gut–brain axis and neurobehavioural alterations induced by maternal immune activation in mice. Behav Pharmacol 29(2):181–198
Mostafa GA, Al-Ayadhi LY (2011) Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflammation 8(1):1–6
Nardone S, Elliott E (2016) The interaction between the immune system and epigenetics in the etiology of autism spectrum disorders. Front Neurosci 329
Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13(10):1161–1169
Newschaffer CJ, Fallin D, Lee NL (2002) Heritable and nonheritable risk factors for autism spectrum disorders. Epidemiol Rev 24(2):137–153
Newschaffer CJ, Croen LA, Daniels J et al (2007) The epidemiology of autism spectrum disorders. Annu Rev Public Health 28:235–258. https://doi.org/10.1146/annurev.publhealth.28.021406.144007
Ochoa-Repáraz J, Mielcarz DW, Ditrio LE et al (2010) Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide a expression. J Immunol 185(7):4101–4108
Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26(3):383–392
Osokine I, Erlebacher A (2017) Inflammation and autism: from maternal gut to fetal brain. Trends Mol Med 23(12):1070–1071
Patterson PH (2009) Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204(2):313–321
Patterson PH (2011) Maternal infection and immune involvement in autism. Trends Mol Med 17(7):389–394
Paysour MJ, Bolte AC, Lukens JR (2019) Crosstalk between the microbiome and gestational immunity in autism-related disorders. DNA Cell Biol 38(5):405–409
Reigstad CS, Salmonson CE, Rainey JF III et al (2015) Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 29(4):1395–1403
Ruskin DN, Murphy MI, Slade SL, Masino SA (2017) Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder. PLoS One 12(2):e0171643
Sampson TR, Mazmanian SK (2015) Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17(5):565–576
Sanctuary MR, Kain JN, Chen SY et al (2019) Pilot study of probiotic/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms. PLoS One 14(1):e0210064
Sandin S, Lichtenstein P, Kuja-Halkola R, Hultman C, Larsson H, Reichenberg A (2017) The heritability of autism spectrum disorder. JAMA 318(12):1182–1184
Saurman V, Margolis KG, Luna RA (2020) Autism spectrum disorder as a brain-gut-microbiome axis disorder. Dig Dis Sci 65(3):818–828
Schmidt RJ, Hansen RL, Hartiala J et al (2011) Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology 22(4):476
Schwartzer J, Careaga M, Onore C, Rushakoff J, Berman RF, Ashwood P (2013) Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl Psychiatry 3(3):e240
Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167(4):915–932
Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003) Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23(1):297–302
Shi L, Smith SE, Malkova N, Tse D, Su Y, Patterson PH (2009) Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 23(1):116–123
Shin Yim Y, Park A, Berrios J et al (2017) Reversing behavioural abnormalities in mice exposed to maternal inflammation. Nature 549(7673):482–487
Silverman JL, Yang M, Lord C, Crawley JN (2010) Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 11(7):490–502
Siniscalco D, Schultz S, Brigida AL, Antonucci N (2018) Inflammation and neuro-immune dysregulations in autism spectrum disorders. Pharmaceuticals 11(2):56
Sivan A, Corrales L, Hubert N et al (2015) Commensal bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science 350(6264):1084–1089
Slattery J, MacFabe DF, Frye RE (2016) The significance of the enteric microbiome on the development of childhood disease: a review of prebiotic and probiotic therapies in disorders of childhood. Clin Med Insights Pediatr 10:91–107. https://doi.org/10.4137/CMPed.S38338
Strati F, Cavalieri D, Albanese D et al (2017) New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5(1):1–11
Supekar K, Uddin LQ, Khouzam A et al (2013) Brain hyperconnectivity in children with autism and its links to social deficits. Cell Rep 5(3):738–747
Tanabe S, Kinuta Y, Saito Y (2008) Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation. Int J Mol Med 22(2):181–185
Tordjman S, Drapier D, Bonnot O et al (2007) Animal models relevant to schizophrenia and autism: validity and limitations. Behav Genet 37(1):61–78
Tsukada T, Shimada H, Sakata-Haga H, Iizuka H, Hatta T (2019) Molecular mechanisms underlying the models of neurodevelopmental disorders in maternal immune activation relevant to the placenta. Congenit Anom 59(3):81–87
Tye C, Runicles AK, Whitehouse AJ, Alvares GA (2019) Characterizing the interplay between autism spectrum disorder and comorbid medical conditions: an integrative review. Front Psych 751
Urakubo A, Jarskog LF, Lieberman JA, Gilmore JH (2001) Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 47(1):27–36
Vita A, De Peri L, Deste G, Sacchetti E (2012) Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry 2(11):e190–e190
Volk HE, Kerin T, Lurmann F, Hertz-Picciotto I, McConnell R, Campbell DB (2014) Brief report: autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology:44–47
Vuillermot S, Luan W, Meyer U, Eyles D (2017) Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation. Mol Autism 8(1):1–13
Vuong HE, Hsiao EY (2017) Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry 81(5):411–423
Wang X, Yang J, Zhang H, Yu J, Yao Z (2019) Oral probiotic administration during pregnancy prevents autism-related behaviors in offspring induced by maternal immune activation via anti-inflammation in mice. Autism Res 12(4):576–588
Wilke CM, Bishop K, Fox D, Zou W (2011) Deciphering the role of Th17 cells in human disease. Trends Immunol 32(12):603–611
Willner P (1984) The validity of animal models of depression. Psychopharmacology (Berl) 83(1):1–16
Xu G, Strathearn L, Liu B et al (2019) Prevalence and treatment patterns of autism spectrum disorder in the United States, 2016. JAMA Pediatr 173(2):153–159
Xuan IC, Hampson DR (2014) Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PLoS One 9(8):e104433
Yano JM, Yu K, Donaldson GP et al (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161(2):264–276
Yap CX, Henders AK, Alvares GA et al (2021) Autism-related dietary preferences mediate autism-gut microbiome associations. Cell 184(24):5916–5931.e17
Zuckerman L, Weiner I (2005) Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39(3):311–323
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kim, A., Zisman, C.R., Holingue, C. (2022). Influences of the Immune System and Microbiome on the Etiology of ASD and GI Symptomology of Autistic Individuals. In: Savitz, J., Yolken, R.H. (eds) Microorganisms and Mental Health. Current Topics in Behavioral Neurosciences, vol 61. Springer, Cham. https://doi.org/10.1007/7854_2022_371
Download citation
DOI: https://doi.org/10.1007/7854_2022_371
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-24332-5
Online ISBN: 978-3-031-24333-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)